GeneDx Holdings (WGS) Inventory Average (2021 - 2026)

GeneDx Holdings has disclosed Inventory Average across 6 years of filings, most recently posting $13.1 million for Q1 2026.

• In Q1 2026, Inventory Average rose 12.35% year-over-year to $13.1 million; the TTM figure through Mar 2026 stood at $13.1 million (up 12.35% YoY), while the FY2025 annual figure was $12.3 million, up 26.63% from the prior year.
• Inventory Average rose to $13.1 million in Q1 2026, from $12.3 million in the prior quarter.
• Over the last five years, Inventory Average for WGS reached as high as $42.9 million in Q3 2022 and fell as low as $9.1 million in Q4 2023.
• The 5-year median for Inventory Average is $11.9 million (2023), against an average of $17.2 million.
• Annual changes were most pronounced in 2022 — Inventory Average jumped 42.24% — and 2023, when it slumped 75.66%.
• A 5-year view of Inventory Average shows it stood at $28.9 million in 2022, then plunged by 68.66% to $9.1 million in 2023, then advanced by 18.17% to $10.7 million in 2024, then advanced by 14.47% to $12.3 million in 2025, then advanced by 6.82% to $13.1 million in 2026.
• According to Business Quant data, Inventory Average over the past three periods registered $13.1 million, $12.3 million, and $11.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.